C
Coya Therapeutics
1 follower
Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.
Org chart
Howard Berman
CEO & Chairman
Collapse
David S. Snyder
CFO & COO
Gregory MacMichael
Chief Technical Officer
Aaron Thome
Head, Neuroinflammation Platform
Arun Swaminathan
Chief Executive Officer/member Of The Board
Fred Grossman D.O., FAPA
President and Chief Medical Officer
Board & advisors
Hideki Garren
Director
Anabella Villalobos
Director
Dov Goldstein
Director
Shimon Sakaguchi
Advisor
Lawrence Steinman
Advisor
Clive Svendsen
Advisor
Malcolm Brenner
Advisor
Stanley Appel
Advisor
Teams
Offices
Similar companies
Liberty University
5 followers
Dyno Therapeutics
4 followers
Cellares
2 followers
Gilead Sciences
148 followers
Regeneron
111 followers
Illumina
76 followers
Agilent Technologies
77 followers
Verily Life Sciences
42 followers
Alexion Pharmaceuticals
41 followers
GRAIL
27 followers
Springside Chestnut Hill Academy
33 followers
Explore companies